BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...
Curia, a leading contract research, development and manufacturing organization, announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...